Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN | Cumberland Pharmaceuticals | N-050824 DISCN | 2011-02-08 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VOQUEZNA TRIPLE PAK | Phathom Pharmaceuticals | N-215152 RX | 2022-05-03 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
biaxin | New Drug Application | 2012-02-22 |
clarithromycin | ANDA | 2024-02-01 |
clarithromycin clarithromycin | ANDA | 2018-02-14 |
clarithromycin extended release | 2008-08-08 | |
lansoprazole, amoxicillin, clarithromycin | ANDA | 2023-09-18 |
omeclamox-pak | New Drug Application | 2023-08-17 |
prevpac | New Drug Application | 2010-03-15 |
voquezna dual pak voquezna triple pak | New Drug Application | 2023-11-06 |
Expiration | Code | ||
---|---|---|---|
AMOXICILLIN / CLARITHROMYCIN / VONOPRAZAN FUMARATE, VOQUEZNA TRIPLE PAK, PHATHOM | |||
2032-05-03 | GAIN | ||
2027-05-03 | NCE |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | 4 | 6 | 17 | 68 | 48 | 139 |
Healthy volunteers/patients | — | — | — | 31 | — | — | 1 | 6 | 38 |
Gastritis | D005756 | EFO_0000217 | K29.7 | — | 3 | 7 | 9 | 5 | 22 |
Helicobacter infections | D016481 | EFO_1000961 | — | — | 1 | 6 | 6 | 7 | 19 |
Helicobacter pylori | D016480 | NCBITaxon_210 | B96.81 | 2 | 1 | 4 | 11 | 2 | 19 |
Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 5 | 4 | 1 | 3 | 17 |
Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | 1 | — | 9 | 2 | 13 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 1 | 4 | 4 | 2 | 11 |
Pneumonia | D011014 | EFO_0003106 | — | 1 | 1 | 8 | 1 | — | 10 |
Peptic ulcer | D010437 | HP_0004398 | K27 | — | — | 1 | 9 | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 1 | 15 | 4 | — | — | 19 |
Mycobacterium avium-intracellulare infection | D015270 | EFO_0007386 | — | 1 | 5 | 4 | — | 3 | 13 |
Lymphoma | D008223 | — | C85.9 | 1 | 3 | 1 | — | 1 | 6 |
Respiratory tract infections | D012141 | — | J06.9 | — | — | 1 | — | 4 | 5 |
Covid-19 | D000086382 | — | U07.1 | — | 1 | 2 | — | 1 | 4 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 1 | 1 | — | 1 | 4 |
Bronchitis | D001991 | — | J40 | — | — | 1 | — | 3 | 4 |
Aggressive periodontitis | D010520 | EFO_0006342 | K05.2 | — | 2 | 2 | — | 2 | 4 |
Buruli ulcer | D054312 | EFO_1001281 | A31.1 | — | 3 | 2 | — | — | 3 |
Bronchopulmonary dysplasia | D001997 | — | P27.8 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
B-cell lymphoma marginal zone | D018442 | — | C88.4 | — | 1 | — | — | 2 | 3 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 2 |
Narcolepsy | D009290 | HP_0030050 | G47.4 | — | 2 | — | — | — | 2 |
Idiopathic hypersomnia | D020177 | — | G47.11 | — | 2 | — | — | — | 2 |
Virus diseases | D014777 | — | B34 | — | 1 | — | — | — | 1 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Squamous cell neoplasms | D018307 | — | — | — | 1 | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug interactions | D004347 | — | — | 7 | — | — | — | 1 | 8 |
Pharmacokinetics | D010599 | — | — | 5 | — | — | — | — | 5 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | 1 | — | — | — | — | 1 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | — | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | — | 1 |
Oxidative stress | D018384 | EFO_1001905 | — | 1 | — | — | — | — | 1 |
Mycoses | D009181 | — | B35-B49 | 1 | — | — | — | — | 1 |
Anovulation | D000858 | — | — | 1 | — | — | — | — | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Patient compliance | D010349 | — | — | — | — | — | — | 2 | 2 |
Tracheitis | D014136 | EFO_0007518 | — | — | — | — | — | 2 | 2 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 1 | 1 |
Staphylococcus aureus | D013211 | NCBITaxon_1280 | — | — | — | — | — | 1 | 1 |
Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | — | — | — | — | 1 | 1 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | — | 1 | 1 |
Radiotherapy | D011878 | — | — | — | — | — | — | 1 | 1 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 1 | 1 |
Drug resistance | D004351 | — | Z16.30 | — | — | — | — | 1 | 1 |
Glomerulonephritis | D005921 | HP_0000099 | N05 | — | — | — | — | 1 | 1 |
Drug common name | Clarithromycin |
INN | clarithromycin |
Description | Clarithromycin is the 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis. It has a role as an antibacterial drug, a protein synthesis inhibitor, an environmental contaminant and a xenobiotic. |
Classification | Small molecule |
Drug class | antibiotics (Streptomyces strain) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O |
PDB | — |
CAS-ID | 81103-11-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1741 |
ChEBI ID | 3732 |
PubChem CID | 84029 |
DrugBank | DB01211 |
UNII ID | H1250JIK0A (ChemIDplus, GSRS) |